tiprankstipranks
Oncolytics Biotech (ONCY)
NASDAQ:ONCY
US Market
ONCY
Oncolytics Biotech
RESEARCH TOOLSreports

Oncolytics Biotech (ONCY) Stock News & Sentiment

1,543 Followers
Oncolytics Biotech: Buy Rating on Pelareorep’s Advancing Registrational Path and Oncolytic Virus Sector Tailwinds
Premium
Ratings
Oncolytics Biotech: Buy Rating on Pelareorep’s Advancing Registrational Path and Oncolytic Virus Sector Tailwinds
3d ago
ONCY
Oncolytics Biotech Establishes $75 Million ATM Offering
Premium
Company Announcements
Oncolytics Biotech Establishes $75 Million ATM Offering
5d ago
8K
ONCY
Oncolytics Plans FDA Meeting for Pelareorep SCAC Study
Premium
Company Announcements
Oncolytics Plans FDA Meeting for Pelareorep SCAC Study
5d ago
8K
ONCY
Oncolytics Biotech Completes Domestication to Nevada with New Governance
Premium
Company Announcements
Oncolytics Biotech Completes Domestication to Nevada with New Governance
10d ago
8K
ONCY
Oncolytics Biotech Shifts Corporate Domicile to British Columbia
Premium
Company Announcements
Oncolytics Biotech Shifts Corporate Domicile to British Columbia
22d ago
8K
ONCY
Oncolytics Biotech Showcases Pelareorep as Immune-Priming Backbone With New AACR 2026 Data
Premium
Company Announcements
Oncolytics Biotech Showcases Pelareorep as Immune-Priming Backbone With New AACR 2026 Data
23d ago
ONCY
Oncolytics Highlights New Pelareorep Data in Cancer Immunotherapy
Premium
Company Announcements
Oncolytics Highlights New Pelareorep Data in Cancer Immunotherapy
23d ago
8K
ONCY
More ONCY News >

ONCY News on the Web

Analysts Offer Insights on Healthcare Companies: Oncolytics Biotech (ONCY) and Nurix Therapeutics (NRIX)
TipRanks News
Bullish
Analysts Have Conflicting Sentiments on These Healthcare Companies: ArriVent BioPharma, Inc. (AVBP) and Oncolytics Biotech (ONCY)
TipRanks News
Neutral
Oncolytics Biotech: Buy Rating on Pelareorep’s Advancing Registrational Path and Oncolytic Virus Sector Tailwinds
TipRanks News
Neutral
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks News
Bullish
Oncolytics price target lowered to $5 from $7 at Lake Street
TipRanks News
Neutral
Analysts Conflicted on These Healthcare Names: Oncolytics Biotech (ONCY) and Neurocrine (NBIX)
TipRanks News
Neutral
Oncolytics Biotech Establishes $75 Million ATM Offering
TipRanks News
Neutral
Oncolytics Plans FDA Meeting for Pelareorep SCAC Study
TipRanks News
Neutral

News Score - Last 7 Days

Very Positive
ONCY
Sector Average
Media Buzz
This Week10 articles
Weekly Average4.25 articles
News Sentiment
This Week100%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ONCY’s Media Buzz Sentiment?
10 articles about ONCY were published this week. In an average week, 4.25 articles are published.
    What is ONCY’s weekly average amount of articles?
    In an average week, 4.25 articles about ONCY are published.
      What is ONCY’s News Sentiment?
      100% of articles about ONCY were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        AORTArtivion
        NBIXNeurocrine
        STAAStaar Surgical
        SLPSimulations Plus
        OWLTOwlet
        Showing the stocks with the most bullish news sentiment over the past week